These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298 [TBL] [Abstract][Full Text] [Related]
6. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT. Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099 [TBL] [Abstract][Full Text] [Related]
8. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575 [TBL] [Abstract][Full Text] [Related]
9. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease. Eshuis SA; Maguire RP; Leenders KL; Jonkman S; Jager PL Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):200-9. PubMed ID: 16228235 [TBL] [Abstract][Full Text] [Related]
10. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease. Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781 [TBL] [Abstract][Full Text] [Related]
11. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study. Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904 [TBL] [Abstract][Full Text] [Related]
12. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Extrastriatal Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628 [No Abstract] [Full Text] [Related]
14. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365 [TBL] [Abstract][Full Text] [Related]
15. Correlating Parkinson's disease motor symptoms with three-dimensional [(18)F]FP-CIT PET. Chung M; Park YS; Kim JS; Kim YJ; Ma HI; Jang SJ; Huh R; Kim HS; Kim WC Jpn J Radiol; 2015 Oct; 33(10):609-18. PubMed ID: 25952404 [TBL] [Abstract][Full Text] [Related]